Search research articles
Contact Us
Filters
Showing results (481-490 of 537) with videos related to
Page
of 54
Sort By:
The Journal of Hand Surgery
|
March 9, 2025
Development of an Amyloidosis Risk Score for Positive Tenosynovial Biopsy at Carpal Tunnel Release
Dafang Zhang, Brandon E Earp, Kyra A Benavent, et al.
Circulation. Cardiovascular Imaging
|
March 3, 2025
Echocardiographic Characterization of Myocardial Stiffness in Healthy Volunteers, Cardiac Amyloidosis, and Hypertrophic Cardiomyopathy: A Case-Control Study Using Multimodality Imaging
Dominik C Benz, Ali Sadeghi, Pat G Rafter, et al.
Bone Marrow Transplantation
|
December 17, 2003
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial
V Sanchorawala, D G Wright, D C Seldin, et al.
JACC. Cardiovascular Imaging
|
September 7, 2023
Cardiac Amyloid Quantification Using <sup>124</sup>I-Evuzamitide (<sup>124</sup>I-P5+14) Versus <sup>18</sup>F-Florbetapir: A Pilot PET/CT Study
Olivier F Clerc, Sarah A M Cuddy, Matthew Robertson, et al.
EMBO Molecular Medicine
|
October 17, 2014
Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity
Jian Guan, Shikha Mishra, Yiling Qiu, et al.
American Journal of Hematology
|
July 27, 2005
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004
Morie A Gertz, Ray Comenzo, Rodney H Falk, et al.
Scientific Data
|
October 17, 2020
TILES-2018, a longitudinal physiologic and behavioral data set of hospital workers
Karel Mundnich, Brandon M Booth, Michelle L'Hommedieu, et al.
EMBO Molecular Medicine
|
May 6, 2015
Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity
Jian Guan, Shikha Mishra, Yiling Qiu, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
August 11, 2024
Quantitative <sup>99m</sup>Tc-pyrophosphate myocardial uptake: Changes on transthyretin stabilization therapy
Shilpa Vijayakumar, Ardel Romero Pabon, Olivier F Clerc, et al.
European Heart Journal. Cardiovascular Imaging
|
December 8, 2025
Evaluating natural history and treatment response in cardiac amyloidosis: the evolving role of multimodality imaging
Amely Walser, Christoph Gräni, Simon F Stämpfli, et al.
Page
of 54
Search research articles
Search
Showing results (481-490 of 537) with videos related to
Sort By:
Page
of 54
The Journal of Hand Surgery
|
March 9, 2025
Development of an Amyloidosis Risk Score for Positive Tenosynovial Biopsy at Carpal Tunnel Release
Dafang Zhang, Brandon E Earp, Kyra A Benavent, et al.
Circulation. Cardiovascular Imaging
|
March 3, 2025
Echocardiographic Characterization of Myocardial Stiffness in Healthy Volunteers, Cardiac Amyloidosis, and Hypertrophic Cardiomyopathy: A Case-Control Study Using Multimodality Imaging
Dominik C Benz, Ali Sadeghi, Pat G Rafter, et al.
Bone Marrow Transplantation
|
December 17, 2003
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial
V Sanchorawala, D G Wright, D C Seldin, et al.
JACC. Cardiovascular Imaging
|
September 7, 2023
Cardiac Amyloid Quantification Using <sup>124</sup>I-Evuzamitide (<sup>124</sup>I-P5+14) Versus <sup>18</sup>F-Florbetapir: A Pilot PET/CT Study
Olivier F Clerc, Sarah A M Cuddy, Matthew Robertson, et al.
EMBO Molecular Medicine
|
October 17, 2014
Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity
Jian Guan, Shikha Mishra, Yiling Qiu, et al.
American Journal of Hematology
|
July 27, 2005
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004
Morie A Gertz, Ray Comenzo, Rodney H Falk, et al.
Scientific Data
|
October 17, 2020
TILES-2018, a longitudinal physiologic and behavioral data set of hospital workers
Karel Mundnich, Brandon M Booth, Michelle L'Hommedieu, et al.
EMBO Molecular Medicine
|
May 6, 2015
Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity
Jian Guan, Shikha Mishra, Yiling Qiu, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
August 11, 2024
Quantitative <sup>99m</sup>Tc-pyrophosphate myocardial uptake: Changes on transthyretin stabilization therapy
Shilpa Vijayakumar, Ardel Romero Pabon, Olivier F Clerc, et al.
European Heart Journal. Cardiovascular Imaging
|
December 8, 2025
Evaluating natural history and treatment response in cardiac amyloidosis: the evolving role of multimodality imaging
Amely Walser, Christoph Gräni, Simon F Stämpfli, et al.
Page
of 54